Treatment with an all-oral regimen led to three-year overall survival and relapse-free survival rates of 97% in patients with acute promyelocytic leukemia, a subset of acute myeloid leukemia.

Asparaginase-containing pediatric-inspired regimens (PIRs) are underutilized in adolescents and young adults with acute lymphoblastic leukemia (ALL), despite reducing inpatient days and treatment ...

Panelists discuss how future AML treatment will likely involve sophisticated decisions about triplet combinations, optimal sequencing of targeted agents, and balancing efficacy with toxicity through ...

Please provide your email address to receive an email when new articles are posted on . The combination is the first all-oral, fixed duration treatment for patients with CLL and or small lymphocytic ...

Please provide your email address to receive an email when new articles are posted on . Three all-oral 9-month treatments for drug-resistant tuberculosis were found to be noninferior to standard ...

PRINCETON, N.J., Dec. 8, 2025 /PRNewswire/ -- Taiho Oncology, Inc., a company developing and commercializing novel treatments for hematologic malignancies and solid tumors, today announced new data ...

Of 13,900 articles, 125 met abstraction criteria. Data spanned 36 countries (6.4% low-income, 43.2% lower-middle–income, 50.4% upper-middle–income) and 163 regimens, of which 138 (84.6%) referenced a ...

Nagpur: Short-duration, all-oral treatment regimens used in India for drug-resistant tuberculosis (TB) are not only cost-effective but also deliver superior health outcomes compared to longer ...